Onkologische Embolisation

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Angiofibel

• Publication date

  2020-11-29

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-3-662-56243-7_14
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Gastroenteropancreatic Neuroendocrine Tumours

  2019cited by this paper
• A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study

  2016cited by this paper
• Current status of transarterial radioembolization.

  2016cited by this paper
• Meta-analysis of phase II trials in metastatic uveal melanoma (MUM) to determine progression-free (PFS) and overall survival (OS) benchmarks for future phase II trials: An irci-ocular melanoma initiative.

  2016cited by this paper
• Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

  2016cited by this paper
• Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization

  2016cited by this paper
• Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review

  2016cited by this paper
• Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion

  2016cited by this paper
• ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

  2016cited by this paper
• Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma

  2016cited by this paper
• Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short‐term results

  2016cited by this paper
• Single centre experience of chemosaturation percutaneous hepatic perfusion in the treatment of metastatic uveal melanoma.

  2015cited by this paper
• Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.

  2015cited by this paper
• Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study

  2015cited by this paper
• Predisposing Factors of Liver Necrosis after Transcatheter Arterial Chemoembolization in Liver Metastases from Neuroendocrine Tumor

  2015cited by this paper
• Interventional radiology: role in the treatment of liver metastases from GEP-NETs

  2015cited by this paper
• Safety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma

  2015cited by this paper
• Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma

  2015cited by this paper
• Bone metastases and skeletal-related events from neuroendocrine tumors

  2015cited by this paper
• Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer

  2015cited by this paper
• Preliminary findings of arterial embolization with balloon-occluded and flow-dependent histoacryl glue embolization in a swine model

  2015cited by this paper
• Transarterial chemoembolization of unresectable systemic chemotherapy‐refractory liver metastases from colorectal cancer: Long‐term results over a 10‐year period

  2014cited by this paper
• Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

  2014cited by this paper
• Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.

  2014cited by this paper
• Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers

  2014cited by this paper
• [National S3 guidelines on hepatocellular carcinoma].

  2014cited by this paper
• Transcatheter Arterial Chemoembolization (TACE) of Colorectal Cancer Liver Metastases by Irinotecan-Eluting Microspheres in a Salvage Patient Population

  2014cited by this paper
• The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.

  2014cited by this paper
• Chemoembolization of Extrahepatic Collateral Arteries for Treatment of Hepatocellular Carcinoma in the Caudate Lobe of the Liver

  2014cited by this paper
• Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.

  2014cited by this paper
• Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience

  2014cited by this paper
• Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases.

  2014cited by this paper
• Recommendations for management of patients with neuroendocrine liver metastases.

  2014cited by this paper
• Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.

  2013cited by this paper
• Transarterial chemoembolization of hepatocellular carcinoma – agents and drugs: an overview. Part 2

  2013cited by this paper
• A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer

  2013cited by this paper
• Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors.

  2013cited by this paper
• Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury

  2013cited by this paper
• Transarterial chemoembolisation (TACE) with gemcitabine: phase II study in patients with liver metastases of breast cancer.

  2013cited by this paper
• Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.

  2013cited by this paper
• Intra-Arterial Liver-Directed Therapies for Neuroendocrine Hepatic Metastases

  2013cited by this paper
• Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.

  2013cited by this paper
• Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review.

  2013cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Functional Anatomy of Liver Circulation

  2012cited by this paper
• Chemosaturation with Percutaneous Hepatic Perfusion for Unresectable Isolated Hepatic Metastases from Sarcoma

  2012cited by this paper
• Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.

  2012cited by this paper
• Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

  2012cited by this paper
• Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres

  2012cited by this paper
• Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin

  2012cited by this paper
• Irinotecan Loaded in Eluting Beads: Preclinical Assessment in a Rabbit VX2 Liver Tumor Model

  2012cited by this paper
• [Transarterial ablation of hepatocellular carcinoma. Status and developments].

  2012cited by this paper
• Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases

  2012cited by this paper
• Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.

  2012cited by this paper
• Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success

  2012cited by this paper
• Radioembolization for Hepatocellular Carcinoma: A Review of the Evidence and Treatment Recommendations

  2011cited by this paper
• The epidemiology of gastroenteropancreatic neuroendocrine tumors.

  2011cited by this paper
• Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

  2011cited by this paper
• Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol

  2011cited by this paper
• Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.

  2011cited by this paper
• Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.

  2011cited by this paper
• ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

  2011cited by this paper
• Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.

  2011cited by this paper
• The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors

  2011cited by this paper
• Assessment of the treatment response of HCC

  2011cited by this paper
• Selective Intra-arterial Chemotherapy with Floxuridine as Second- or Third-Line Approach in Patients with Unresectable Colorectal Liver Metastases

  2011cited by this paper
• Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol

  2011cited by this paper
• Hepatic Arterial Chemoembolization Using Drug-Eluting Beads in Gastrointestinal Neuroendocrine Tumor Metastatic to the Liver

  2011cited by this paper
• Acute Tumor Lysis Syndrome after Transarterial Chemoembolization for Well-Differentiated Hepatocellular Carcinoma with Neuroendocrine Features

  2010cited by this paper
• ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors

  2010cited by this paper
• Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma

  2010cited by this paper
• ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors

  2010cited by this paper
• Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

  2010cited by this paper
• Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases

  2010cited by this paper
• ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors

  2010cited by this paper
• Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.

  2010cited by this paper
• Arterial patency after repeated hepatic artery bland particle embolization.

  2010cited by this paper
• Transarterial chemoembolization of liver metastases in patients with uveal melanoma.

  2010cited by this paper
• Development of Isolated Hepatic Perfusion via the Operative and Percutaneous Techniques for Patients With Isolated and Unresectable Liver Metastases

  2010cited by this paper
• Bland Embolization in Patients with Unresectable Hepatocellular Carcinoma Using Precise, Tightly Size-Calibrated, Anti-Inflammatory Microparticles: First Clinical Experience and One-Year Follow-Up

  2010cited by this paper
• In vitro characterization of cisplatin-loaded superabsorbent polymer microspheres designed for chemoembolization.

  2010cited by this paper
• Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

  2009cited by this paper
• Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center

  2009cited by this paper
• Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review.

  2009cited by this paper
• Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.

  2009cited by this paper
• Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report

  2009cited by this paper
• Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

  2009cited by this paper
• Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients.

  2008cited by this paper
• Drug-Loaded Microspheres for the Treatment of Liver Cancer: Review of Current Results

  2008cited by this paper
• Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients

  2008cited by this paper
• Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?

  2008cited by this paper
• Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma

  2008cited by this paper
• Biocompatibility and Recanalization Characteristics of Hydrogel Microspheres with Polyzene-F as Polymer Coating

  2008cited by this paper
• Chemoembolization (TACE) of Unresectable Intrahepatic Cholangiocarcinoma with Slow-Release Doxorubicin-Eluting Beads: Preliminary Results

  2008cited by this paper
• Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization

  2008cited by this paper
• Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.

  2008cited by this paper
• One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

  2008cited by this paper
• Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.

  2008cited by this paper
• Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness

  2008cited by this paper
• Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

  2008cited by this paper

• No citing papers are available for this paper.